Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
65.60
Ask:
70.00
Spread: 4.40 (6.707%)
Market Cap: £89.08m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Trading Statement

29 Apr 2026 07:00

RNS Number : 2934C
Trifast PLC
29 April 2026
 

 

 

 

 

 

29 April 2026

TRIFAST PLC

FY26 Trading Update & Notice of Results

- FY26 underlying EBIT expected to be in line with market expectations

- Further EBIT margin enhancement and on track to deliver EBIT margins > 10% in medium term

- Strong working capital discipline continues to generate cash and deliver leverage <1x

Trifast plc ("Trifast" or the "Group," LSE: TRI.L), the international specialist in the design, engineering, manufacture, and distribution of high‑quality engineered fastenings, today announces a Trading Update for the year ended 31 March 2026 ("FY26"), ahead of the publication of its final results in July.

Trading Update

The Group expects to report FY26 underlying EBIT of c.£16.0m, in line with market expectations1, reflecting continued margin improvement from delivery of our strategic self‑help initiatives, against a challenging macroeconomic and geopolitical backdrop.

Revenues for FY26 declined by approximately 7.0% year‑on‑year, to c.£207.0m, driven primarily by lower volumes and exit of low margin customers. This reflects subdued demand in a number of markets, caused by tariff disruption as well as ongoing weakness in the automotive sector. Despite this challenging backdrop, the Group has improved gross profit margins by a further c.150bps, to c.30%, alongside operational improvements in both productivity and cost efficiency.

Group EBIT margins are expected to improve to approximately 7.8% (2025: 6.7%) reflecting the ongoing impact of self‑help actions, including inventory discipline and the sale of excess and obsolete stock.

The Group's balance sheet remains robust with leverage remaining below 1.0x, supported by disciplined cash management and a continued focus on working capital.

As part of the Group's Recover, Rebuild, Resilience strategy, the Board has been reviewing the suitability of its global manufacturing footprint and has taken the decision to close its manufacturing operations in Malaysia.

Manufacturing footprint optimisation

The optimisation of the footprint will include retention of a sales and distribution hub in Malaysia, with the intention over time to develop a shared services capability, leveraging the model successfully established in Hungary.

The closure will reduce fixed costs, simplify the footprint in Asia and the positive mix impact will accelerate progress towards our returns target. It will also allow management focus and capital to be redeployed towards higher growth regions, including China and India, where momentum, particularly in India, is increasingly evident.

Outlook

The Group continues to monitor the direct and indirect impacts of geopolitical developments, including the ongoing conflict involving Iran, and the associated effects on regional customer activity and supply chains. In particular, a customer operating in Saudi Arabia has experienced disruption as a result of the current environment, which is expected to adversely affect revenues in the region.

The Group has developed an increasingly agile operating model to respond effectively to external shocks and has demonstrated its ability to manage costs within its control over the past few years of volatile trading conditions. Any increased costs will be addressed through a combination of pricing and operational measures, in line with the Group's established commercial discipline.

The Group's diversified footprint, broad supplier base and pricing capability provide resilience in managing volatility as well as supporting its competitive advantage in service delivery. Having worked hard to refine the commercial approach and focus on target markets, it is encouraging that the Group is seeing its strongest commercial pipeline in the last two years, as customers place increased emphasis on supply chain and engineered solutions, quality of service, reliability, and continuity.

As a result of the closure of the Malaysian manufacturing operation and on-going conflicts in the Middle East, FY27 revenue will be reduced by c.£8.0m.

 

Iain Percival, CEO of Trifast, said:

"FY26 reflects continued progress in strengthening the business, with clear structural margin improvement despite weaker volumes, particularly in automotive.

After a considered review of our footprint, we have taken the decision to exit manufacturing in Malaysia from April 2026. This is a positive step that optimises the business, retaining local market commercial capability whilst accelerating progress on margins and return on capital.

While the external environment remains challenging, we are encouraged by our strongest commercial pipeline for two years, as customers in our focus markets place increased emphasis on quality of service and reliability. We remain confident in our medium‑term prospects and >10% EBIT margin target driven by the continued successful delivery of our Recover, Rebuild, Resilience strategy."

Notice of FY26 Annual Results

The Group expects to announce its FY26 Annual Results on 2 July 2026.

 

Notes:

1 Consensus forecasts for FY26 prior to this announcement were revenue of £214.0m, underlying EBIT of £16.0m. Consensus is calculated

 by reference to the average of the estimates published by three analysts.

 

 

Enquiries please contact:

Trifast plc

Iain Percival, Chief Executive Officer

Kate Ferguson, Chief Financial Officer

Christopher Morgan, Company Secretary

Office: +44 (0) 1825 747630

Email: corporate.enquiries@trifast.com

Shareholders: companysecretariat@trifast.com

Peel Hunt LLP (Stockbroker & financial adviser)

Mike Bell

Tel: +44 (0)20 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGCCUPQGRR
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.